In the study, lidocaine is given as a continuous infusion during the anesthesia period. Blood samples are taken at different times so that the amount of lidocaine in the blood can be checked. The study also follows pain after surgery and any side effects that may be related to lidocaine, as well as the use of pain medicine after the procedure.

The information from this trial may help improve understanding of how age can change the effect and behavior of lidocaine in the body. This may support safer and more appropriate use of the drug in different age groups.

The purpose of the study is to evaluate how well these two anesthetics work in providing pain relief during eye exams. The study will involve applying either the eye gel or the eye drops to the surface of the eye and observing the level of anesthesia achieved. The study will also monitor any side effects or reactions to the treatments, ensuring the safety and comfort of the participants. The trial is designed to be observer-blind, meaning the person assessing the results does not know which treatment the participant received, to ensure unbiased results.

Participants will be randomly assigned to receive either the Chloroprocaine Hydrochloride gel or the Oxybuprocaine drops. The study will take place over a short period, with the primary focus on the effectiveness of the anesthesia five minutes after application, just before the eye examination. Safety will be closely monitored throughout the study, with any adverse effects being recorded and evaluated. The study aims to provide valuable information on which anesthetic is more effective and better tolerated in children undergoing eye procedures.

Participants in the study will receive either lidocaine hydrochloride or sodium chloride through an intravenous infusion, meaning the substance is delivered directly into a vein. The study period covers the time around the surgery and the first 48 hours after the breathing tube is removed. Various factors such as pain levels, the amount of pain medication used, the length of time spent in the hospital, and the risk of other issues like pneumonia or acute kidney insufficiency will be observed during the recovery process.

The main purpose is to determine if adding intravenous lidocaine to spinal morphine works better than using a placebo with spinal morphine for reducing the need for additional pain medication after surgery. The study compares two groups of patients – one receiving lidocaine and the other receiving placebo, along with spinal morphine.

During the study, patients undergo their planned abdominal surgery and receive either lidocaine or placebo through an intravenous line. The medication or placebo is given during and after the operation. Both groups receive spinal morphine as part of their pain management plan. The amount of additional pain medication needed and any side effects are monitored for several days after surgery.

The purpose of this research is to determine which of these medication options works best for safely putting patients to sleep and placing a breathing tube, while maintaining stable blood pressure. The medications will be given through an intravenous injection, which means they are delivered directly into a vein. The study will look at how well each medication option works in helping doctors successfully place the breathing tube on the first try without causing a dangerous drop in blood pressure.

During the study, patients will receive one of the three medication options before their planned surgery. The medical team will monitor vital signs including blood pressure, heart rate, and oxygen levels for 10 minutes after giving the medication. Patients will also be checked for any side effects while in the recovery room after surgery and for up to one week afterward.

The medications being studied in this trial include DEXAMETHASONE SODIUM PHOSPHATE, ROPIVACAINE, and LIDOCAINE HYDROCHLORIDE. DEXAMETHASONE SODIUM PHOSPHATE is a corticosteroid used to reduce inflammation. ROPIVACAINE and LIDOCAINE HYDROCHLORIDE are local anesthetics, which means they are used to numb a specific area of the body to prevent pain during procedures. These medications are administered through injections, with ROPIVACAINE and LIDOCAINE HYDROCHLORIDE being used for local anesthesia, and DEXAMETHASONE SODIUM PHOSPHATE potentially being used to enhance the effects of the anesthetics.

The purpose of the study is to assess how effective the serratus plane block is compared to local anesthesia in managing acute pain during pleural drainage. Participants in the study will receive one of these pain management methods during their procedure. The study will monitor the intensity of pain experienced during and after the procedure, as well as any potential side effects or complications. The trial aims to provide valuable information on the best approach to pain management for patients undergoing pleural drainage in intensive care settings.

Participants in the study will undergo the open inguinal hernia mesh repair procedure, which is a common surgery to fix hernias in the groin area. The study will observe the patients for a period of three months after their surgery to assess the incidence of chronic pain. The goal is to determine if the timing of the TAP block can help prevent chronic pain and reduce the need for long-term use of pain-relief medications.

This study aims to provide valuable insights into pain management strategies for patients undergoing this type of hernia repair, potentially improving recovery experiences and outcomes. By understanding the impact of the TAP block’s timing, healthcare providers can better tailor pain management approaches to enhance patient comfort and reduce the risk of chronic pain after surgery.

In this study, two medications are being used. The first is Ropivacaine hydrochloride, which is a regional anesthetic provided as a solution for infusion. The second is Lidocaine hydrochloride, a local anesthetic given as a solution for injection. These medications help numb the area where the device is implanted, reducing pain during and after the procedure. Some patients will receive a placebo instead of one of these medications to compare the effects.

Participants in the trial will be randomly assigned to one of two groups, each receiving a different type of anesthesia. The study will monitor the patients’ recovery and comfort levels for 24 hours after the procedure, using the QoR-15 score. Additional factors such as the need for extra pain relief, the stability of vital signs, and the length of hospital stay will also be observed. The trial is designed to provide valuable insights into which anesthesia method offers better comfort and recovery for patients undergoing CIED implantation.

The study involves the use of two medications: Midazolam, also known by its code name USL-261, which is used for sedation, and Bupivacaine, which is used for spinal anaesthesia. Midazolam is administered as a solution for injection or infusion, while Bupivacaine is given as an injectable solution. Participants in the study will receive either spinal anaesthesia or sedation during the procedure, and the outcomes will be compared to see which method is more effective.

Throughout the study, participants will be monitored for the success of the procedure, which is defined as the baby being in a head-down position after the procedure. Additionally, any side effects related to the procedure or the anaesthesia, such as changes in blood pressure or heart rate, will be recorded. The study aims to provide valuable information on the best anaesthesia method to use for this procedure, potentially improving outcomes for both mothers and babies.

In addition to chloroprocaine, other medications such as midazolam, fentanyl citrate, tramadol hydrochloride, paracetamol (also known as acetaminophen), and sevoflurane may be used during the study. These medications serve various roles, such as providing sedation, pain relief, or additional anesthesia if needed. The trial aims to assess how many patients do not require additional anesthesia during surgery, as well as other factors like the time it takes for the anesthetic to start working and how long it lasts.

The study is designed to gather information on the overall recovery of patients, including their pain levels and any side effects they might experience. The goal is to ensure that the anesthetic is both effective and safe for use in children undergoing these specific surgeries. Participants will be monitored closely throughout the process to ensure their well-being and to collect valuable data on the anesthetic’s performance.

In this study, some children will receive dexmedetomidine, while others will receive a placebo, which is a solution that does not contain the active medication. The study is designed to be double-blind, meaning neither the participants nor the researchers know who is receiving the actual medication or the placebo, to ensure unbiased results. The main goal is to observe if fewer children need additional pain relief medication after surgery when they receive dexmedetomidine.

Throughout the study, researchers will monitor the children’s pain levels and any side effects they might experience. They will also look at how much additional pain medication is needed and how long the children stay in the recovery area after surgery. The study will also assess the children’s behavior and quality of life after they leave the hospital, at intervals of 7 days, 3 months, and 6 months. This information will help determine the effectiveness and safety of using dexmedetomidine in pediatric surgeries.

The trial involves patients who are scheduled for a specific type of brain surgery called a craniotomy, which is performed to remove tumors from the brain. During the study, participants will receive either Phenylephrine or Noradrenaline Tartrate through an intravenous infusion, which means the medication is delivered directly into the bloodstream. The goal is to observe any differences in how these medications affect the body’s circulation and the brain’s oxygen supply.

The study will monitor changes in blood flow and oxygenation before and after treatment with these medications. By comparing the effects of Phenylephrine and Noradrenaline Tartrate, researchers hope to gain insights into which medication might be more beneficial for maintaining stable blood pressure and ensuring adequate blood flow to the brain during surgery. This research is part of an international effort to improve outcomes for patients undergoing brain tumor surgery.

The medications being studied include sufentanil citrate, remifentanil, and sodium chloride. Sufentanil citrate and remifentanil are types of opioids, which are strong pain-relieving drugs often used during surgeries. Sodium chloride is a simple salt solution that is commonly used in medical settings. These medications will be given through an intravenous injection, which means they are delivered directly into the bloodstream through a vein.

During the study, participants will receive one of these medications, and their heart rate will be monitored to see how it changes from the time they enter the operating room until the end of the intubation process. The study is designed to be double-blind, meaning neither the participants nor the researchers know which medication is being given to each participant, to ensure unbiased results. The findings from this study could help improve the safety and effectiveness of rapid sequence intubation in patients who require it.

The two medications being studied are neostigmine combined with glycopyrrolate, and sugammadex. Neostigmine and glycopyrrolate are given together as a solution for injection, while sugammadex is also given as a solution for injection. The purpose of the study is to determine which medication works faster in reversing the muscle relaxation. The study is designed to be “blinded,” meaning that neither the patients nor the researchers know which medication is being given to each patient, to ensure unbiased results.

Participants in the study will receive either neostigmine/glycopyrrolate or sugammadex after their surgery. The researchers will then measure how quickly the patients’ muscle function returns to normal. The study will also monitor for any signs of muscle weakness or other side effects after the medication is given. The goal is to find out if sugammadex provides a quicker recovery from muscle relaxation compared to neostigmine/glycopyrrolate in elderly patients. This information could help improve recovery times and outcomes for patients undergoing similar surgeries in the future.

The purpose of this study is to determine the most effective dose of these medications for newborn babies who are less than 47 weeks post-conception age. Both medications are given as an injection into a vein, with propofol being administered as an infusion solution and thiopental as an injection solution. The maximum single dose of propofol used in the study is 3 mg per kilogram of body weight, while thiopental is used at up to 5 mg per kilogram of body weight.

During the study, medical staff will carefully monitor how newborns respond to these medications when they are given before surgery or other medical procedures requiring general anesthesia. The medications will be administered just once during the procedure, and doctors will observe how quickly and effectively they work to make the baby unconscious safely.